Diagnostic Performance of Exome Sequencing in Autism Spectrum Disorders

NCT04043351 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-06-06

No results posted yet for this study

Summary

Evaluation of the diagnostic performance of exome sequencing in a prospective series of patients with autism spectrum disorders (ASD).

Conditions

Sponsors & Collaborators

  • University Hospital, Rouen

    lead OTHER

Principal Investigators

  • GAEL NICOLAS · ROUEN HOSPITAL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-12
Primary Completion
2021-10-19
Completion
2021-10-19

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04043351 on ClinicalTrials.gov